Alkyl amines chemicals Limited has completed the allotment of 75 equity shares to eligible employees under its Employee Stock Option Plan 2018 (ESOP-2018) on December 19, 2025. The allotment was approved through a circular resolution passed by the Nomination and Remuneration Committee of the Board of Directors on the same date.

Share Allotment Details

The company allotted 75 equity shares with a face value of ₹2.00 each to eligible employees upon exercise of stock options granted under the AACL-ESOP 2018 scheme. This allotment represents the execution of previously granted employee stock options under the company's established employee benefit program.

Impact on Share Capital

The allotment has resulted in a marginal increase in the company's paid-up equity share capital. The capital structure has been updated to reflect the new share issuance under the employee stock option plan.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification has been filed with both BSE (scrip code: 506767) and NSE (symbol: ALKYLAMINE) as required under SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The original ESOP-2018 scheme filing dates were February 2, 2019 for BSE and February 4, 2019 for NSE. No lock-in period applies to these allotted shares, and they will rank pari passu with existing equity shares of the company.

Listing and Fee Structure

Since the company's paid-up capital remains within the ₹100 crores slab, no additional listing fees are payable for the newly issued equity shares. The company has already paid the requisite listing fees for this capital range, covering the current allotment under the existing fee structure.

The allotment demonstrates the company's commitment to its employee incentive programs while maintaining compliance with all regulatory requirements for listed entities.

Alkyl Amines Chemicals Limited has successfully concluded its postal ballot process, with shareholders overwhelmingly approving the revision in remuneration for Whole-time Director-Operations, Mr. Rakesh S. Goyal. The special resolution received strong support with 99.90% of votes cast in favor of increasing his commission from 0.10% to 0.30% of net profits.

Postal Ballot Results

The voting results, declared on December 22, 2025, demonstrated strong shareholder confidence in the proposed changes:

Approved Remuneration Structure

The shareholders have approved the following commission structure for Mr. Goyal:

Other components of Mr. Goyal's remuneration package remain unchanged, including basic salary ranging from ₹6.00 lakh to ₹7.20 lakh per month with annual increments, house rent allowance at 40% of basic salary, and various benefits such as leave travel assistance, mediclaim policy premium, provident fund, and gratuity.

Voting Process Details

The e-voting process was conducted through National Securities Depository Limited (NSDL) platform from November 21, 2025, to December 20, 2025. The company dispatched postal ballot notices electronically to all eligible shareholders whose names appeared in the register as of the record date of November 14, 2025.

Executive Profile and Rationale

The revision aims to align Mr. Goyal's compensation with industry standards, considering his extensive 30-year experience in manufacturing, technology transfer, process development, quality management, and sales and marketing. Mr. Goyal holds 12,295 equity shares representing 0.02% of the company's paid-up equity share capital and serves as a member of the Risk Management Committee.

The proposal received approval from the Nomination and Remuneration Committee on October 23, 2025, followed by Board approval on November 4, 2025. The resolution is deemed effective from the last date of e-voting, December 20, 2025, with the revised commission structure taking effect from January 1, 2026.